| Literature DB >> 33384998 |
Qian Liu1,2, Mao Li2, Shiyi Wang3, Zhousheng Xiao4, Yuanyuan Xiong1,5, Guangwei Wang1,2.
Abstract
With increasing life expectations, more and more patients suffer from fractures either induced by intensive sports or other bone-related diseases. The balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption is the basis for maintaining bone health. Osterix (Osx) has long been known to be an essential transcription factor for the osteoblast differentiation and bone mineralization. Emerging evidence suggests that Osx not only plays an important role in intramembranous bone formation, but also affects endochondral ossification by participating in the terminal cartilage differentiation. Given its essentiality in skeletal development and bone formation, Osx has become a new research hotspot in recent years. In this review, we focus on the progress of Osx's function and its regulation in osteoblast differentiation and bone mass. And the potential role of Osx in developing new therapeutic strategies for osteolytic diseases was discussed.Entities:
Keywords: bone; osteoblast differentiation; osteolytic diseases; osterix; therapy
Year: 2020 PMID: 33384998 PMCID: PMC7769847 DOI: 10.3389/fcell.2020.601224
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X